Thomas Michel

Thomas Michel

Auto-generated profile, based on publicly available information

Thomas Michel

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 02115, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2016 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CGClaudia Goettsch
Claudia Goettsch
JHJoshua D. Hutcheson
Joshua D. Hutcheson
MAMasanori Aikawa
Masanori Aikawa
HIHiroshi Iwata
Hiroshi Iwata
TPTan Pham
Tan Pham
EAElena Aikawa
Elena Aikawa
Vascular calcification is a common feature of major cardiovascular diseases. Extracellular vesicles participate in the formation of microcalcifications that are implicated in atherosclerotic plaque rupture; however, the mechanisms that regulate formation of calcifying extracellular vesicles remain obscure. Here, we have demonstrated that sortilin is a key regulator of smooth muscle cell (SMC) calcification via its recruitment to extracellular vesicles. Sortilin localized to calcifying vessels in human and mouse atheromata and participated in formation of microcalcifications in SMC culture. Sortilin regulated the loading of the calcification protein tissue nonspecific alkaline phosphatase (TNAP) into extracellular vesicles, thereby conferring its calcification potential. Furthermore, SMC calcification required Rab11-dependent trafficking and FAM20C/casein kinase 2–dependent C-terminal phosphorylation of sortilin. In a murine model, Sort1-deficiency reduced arterial calcification but did not affect bone mineralization. Additionally, transfer of sortilin-deficient BM cells to irradiated atherosclerotic mice did not affect vascular calcification, indicating a primary role of SMC-derived sortilin. Together, the results of this study identify sortilin phosphorylation as a potential therapeutic target for ectopic calcification/microcalcification and may clarify the mechanism that underlies the genetic association between the SORT1 gene locus and coronary artery calcification.

8 September 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JIJunsuke Igarashi
Junsuke Igarashi
PEPhillip A. Erwin
Phillip A. Erwin
ADAna Paula Dantas
Ana Paula Dantas
HCHongjie Chen
Hongjie Chen
TMThomas Michel
Thomas Michel
Sphingosine 1-phosphate (S1P) is a platelet-derived sphingolipid that binds to S1P 1 (EDG-1) receptors and activates the endothelial isoform of NO synthase (eNOS). S1P and the polypeptide growth factor vascular endothelial growth factor (VEGF) act independently to modulate angiogenesis and activate eNOS. In these studies, we explored the cross-talk between S1P and VEGF signaling pathways. When cultured bovine aortic endothelial cells were treated with VEGF (10 ng/ml), the expression of S1P 1 protein and mRNA increased by ≈4-fold. S1P 1 up-regulation by VEGF was seen within 30 min of VEGF addition and reached a maximum after 1.5 h. By contrast, expression of neither bradykinin B2 receptors nor the scaffolding protein caveolin-1 was altered by VEGF treatment. The EC 50 for VEGF-promoted induction of S1P 1 expression was ≈2 ng/ml, within its physiological concentration range. S1P 1 induction by VEGF was attenuated by the tyrosine kinase inhibitor genistein and by the PKC inhibitor calphostin C. Preincubation of bovine aortic endothelial cells with VEGF (10 ng/ml for 90 min) markedly enhanced subsequent S1P-dependent eNOS activation. VEGF pretreatment of cultured endothelial cells also markedly potentiated S1P-promoted eNOS phosphorylation at Ser-1179, as well as S1P-mediated activation of kinase Akt. In isolated rat arteries, VEGF pretreatment markedly potentiated S1P-mediated vasorelaxation and eNOS Ser-1179 phosphorylation. Taken together, these data indicate that VEGF specifically induces expression of S1P 1 receptors, associated with enhanced intracellular signaling responses to S1P and the potentiation of S1P-mediated vasorelaxation. We suggest that VEGF acts to sensitize the vascular endothelium to the effects of lipid mediators by promoting the induction of S1P 1 receptors, representing a potentially important point of cross-talk between receptor-regulated eNOS signaling pathways in the vasculature.

2 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
BSBenjamin Steinhorn
Benjamin Steinhorn
ASAndrea Sorrentino
Andrea Sorrentino
SBSachin Badole
Sachin Badole
YBYulia Bogdanova
Yulia Bogdanova
VBVsevolod Belousov
Vsevolod Belousov
TMThomas Michel
Thomas Michel
Oxidative stress plays an important role in the pathogenesis of many disease states. In the heart, reactive oxygen species are linked with cardiac ischemia/reperfusion injury, hypertrophy, and heart failure. While this correlation between ROS and cardiac pathology has been observed in multiple models of heart failure, the independent role of hydrogen peroxide (H2O2) in vitro and in vivo is unclear, owing to a lack of tools for precise manipulation of intracellular redox state. Here we apply a chemogenetic system based on a yeast D-amino acid oxidase to show that chronic generation of H2O2 in the heart induces a dilated cardiomyopathy with significant systolic dysfunction. We anticipate that chemogenetic approaches will enable future studies of in vivo H2O2 signaling not only in the heart, but also in the many other organ systems where the relationship between redox events and physiology remains unclear.

7 October 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
VMVIRGINIE MONTIEL
VIRGINIE MONTIEL
RBRamona Bella
Ramona Bella
LMLauriane Y.M. Michel
Lauriane Y.M. Michel
HEHrag Esfahani
Hrag Esfahani
DMDelphine De Mulder
Delphine De Mulder
JBJean-luc Balligand
Jean-luc Balligand
Pharmacological inhibition of AQP1 prevents H 2 O 2 transport and hypertrophy of cardiac myocytes.

16 September 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
EEEmrah Eroglu
Emrah Eroglu
SSSeyed Soheil Saeedi Saravi
Seyed Soheil Saeedi Saravi
ASAndrea Sorrentino
Andrea Sorrentino
BSBenjamin Steinhorn
Benjamin Steinhorn
TMThomas Michel
Thomas Michel
Nitric oxide (NO) synthesized by the endothelial isoform of nitric oxide synthase (eNOS) is a critical determinant of vascular homeostasis. However, the real-time detection of intracellular NO—a free radical gas—has been difficult, and surrogate markers for eNOS activation are widely utilized. eNOS phosphorylation can be easily measured in cells by probing immunoblots with phosphospecific antibodies. Here, we pursued multispectral imaging approaches using biosensors to visualize intracellular NO and Ca2+ and exploited chemogenetic approaches to define the relationships between NO synthesis and eNOS phosphorylation in cultured endothelial cells. We found that the G protein-coupled receptor agonists adenosine triphosphate (ATP) and histamine promoted rapid increases in eNOS phosphorylation, as did the receptor tyrosine kinase agonists insulin and Vascular Endothelial Growth Factor (VEGF). Histamine and ATP also promoted robust NO formation and increased intracellular Ca2+. By contrast, neither insulin nor VEGF caused any increase whatsoever in intracellular NO or Ca2+—despite eliciting strong eNOS phosphorylation responses. Our findings demonstrate an unexpected and striking discordance between receptor-modulated eNOS phosphorylation and NO formation in endothelial cells. Previous reports in which phosphorylation of eNOS has been studied as a surrogate for enzyme activation may need to be reassessed. Significance Nitric oxide (NO) is synthesized by the endothelial isoform of nitric oxide synthase (eNOS) in vascular endothelial cells. The high reactivity of NO undermines its accurate detection in living cells. The direct detection of the low physiological concentrations of NO that are present in endothelial cells represents a significant analytical challenge. In these studies, we have used powerful biosensors to measure NO and other key signaling molecules in living endothelial cells in real time using fluorescence microscopy. These approaches have provided insights into the mechanisms whereby NO synthesis is regulated and call into question many prior conclusions about the intracellular pathways that regulate eNOS.

1 April 2021 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JCJohn A. Collins
John A. Collins
MKMaryna Kapustina
Maryna Kapustina
JBJesalyn A. Bolduc
Jesalyn A. Bolduc
JPJames F.W. Pike
James F.W. Pike
BDBrian O. Diekman
Brian O. Diekman
RLRichard F. Loeser
Richard F. Loeser